학술논문
Final overall survival analysis and organ-specific target lesion assessments with two-year follow-up in CheckMate 9ER: Nivolumab plus cabozantinib versus sunitinib for patients with advanced renal cell carcinoma.
Document Type
Journal
Author
Powles, Thomas; Choueiri, Toni K.; Burotto, Mauricio; Escudier, Bernard; Bourlon, Maria Teresa; Shah, Amishi Yogesh; Suarez, Cristina; Hamzaj, Alketa; Porta, Camillo; Hocking, Christopher; Kessler, Elizabeth R.; Gurney, Howard; Tomita, Yoshihiko; Bedke, Jens; Zhang, Joshua; Simsek, Burcin; Scheffold, Christian; Apolo, Andrea B.; Motzer, Robert J.
Source
Subject
Language
English
ISSN
15277755